0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessThese pharmacological alphaPlGF mAb results confirm previous genetic evidence that inhibition of PlGF slows down early atherosclerotic lesion development. Furthermore, the phenocopy of genetic and pharmacological loss-of-function strategies underscores that alphaPlGF acts by selectively neutralizing PlGF.
Carmen Roncal, Ian Buysschaert, Norbert Gerdes, Μαρία Γεωργιάδου, О. А. Овчинникова, Christian Fischer, Jean Marie Stassen, Lieve Moons, Désiré Collen, Katrien De Bock, Göran K. Hansson, Peter Carmeliet (2009). Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions. , 86(1), DOI: https://doi.org/10.1093/cvr/cvp380.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2009
Authors
12
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1093/cvr/cvp380
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
